MedPath

上海理想制药有限公司

Ownership
-
Established
1981-01-08
Employees
-
Market Cap
-
Website
www.ccp.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

34

NMPA:34

Drug Approvals

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20254453
Approval Date
Jun 3, 2025
NMPA

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20254452
Approval Date
Jun 3, 2025
NMPA

Oxcarbazepine Tablets

Product Name
奥卡西平片
Approval Number
国药准字H20253900
Approval Date
Apr 15, 2025
NMPA

Gabapentin Capsules

Product Name
加巴喷丁胶囊
Approval Number
国药准字H20253339
Approval Date
Feb 8, 2025
NMPA

Gabapentin Capsules

Product Name
加巴喷丁胶囊
Approval Number
国药准字H20253338
Approval Date
Feb 8, 2025
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20253015
Approval Date
Jan 2, 2025
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20253016
Approval Date
Jan 2, 2025
NMPA

Atenolol Tablets

Product Name
阿替洛尔片
Approval Number
国药准字H20249782
Approval Date
Dec 25, 2024
NMPA

Atenolol Tablets

Product Name
阿替洛尔片
Approval Number
国药准字H20249783
Approval Date
Dec 25, 2024
NMPA

Fluvoxamine Maleate Tablets

Product Name
马来酸氟伏沙明片
Approval Number
国药准字H20249184
Approval Date
Oct 29, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.